A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans

M Yi, H Li, Z Wu, J Yan, Q Liu, C Ou… - Cellular Physiology and …, 2018 - karger.com
Human neuropeptide Y (hNPY) is one of the most widely expressed neurotransmitters in the
human central and peripheral nervous systems. It consists of 36 highly conserved amino …

The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer

L Zhang, MS Bijker, H Herzog - Pharmacology & therapeutics, 2011 - Elsevier
The neuropeptide Y (NPY) system–comprising of neuropeptide Y, peptide YY, pancreatic
polypeptide and the corresponding Y receptors through which they act (Y1, Y2, Y4, Y5 and …

Integrative genome-scale analysis identifies epigenetic mechanisms of transcriptional deregulation in unfavorable neuroblastomas

KO Henrich, S Bender, M Saadati, D Dreidax… - Cancer research, 2016 - AACR
The broad clinical spectrum of neuroblastoma ranges from spontaneous regression to rapid
progression despite intensive multimodal therapy. This diversity is not fully explained by …

Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma

C Lu, A Mahajan, SH Hong, S Galli, S Zhu… - Nature …, 2022 - nature.com
Adverse prognosis in Ewing sarcoma (ES) is associated with the presence of metastases,
particularly in bone, tumor hypoxia and chromosomal instability (CIN). Yet, a mechanistic …

NPY and gene therapy for epilepsy: how, when,... and Y

S Cattaneo, G Verlengia, P Marino… - Frontiers in molecular …, 2021 - frontiersin.org
Neuropeptide Y (NPY) is a neuropeptide abundantly expressed in the mammalian central
and peripheral nervous system. NPY is a pleiotropic molecule, which influences cell …

Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors

C Morgat, AK Mishra, R Varshney… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Receptors for some regulatory peptides are highly expressed in tumors. Selective
radiolabeled peptides can bind with high affinity and specificity to these receptors and …

Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment

S Shalabi, A Belayachi, B Larrivée - Frontiers in Immunology, 2024 - frontiersin.org
Emerging evidence suggests that nerves within the tumor microenvironment play a crucial
role in regulating angiogenesis. Neurotransmitters and neuropeptides released by nerves …

Neuropeptide Y peptide family and cancer: Antitumor therapeutic strategies

ML Sánchez, FD Rodríguez, R Coveñas - International Journal of …, 2023 - mdpi.com
Currently available data on the involvement of neuropeptide Y (NPY), peptide YY (PYY), and
pancreatic polypeptide (PP) and their receptors (YRs) in cancer are updated. The structure …

Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development

C Walther, K Mörl… - Journal of Peptide …, 2011 - Wiley Online Library
Abstract NPY, PYY and PP constitute the so‐called NPY hormone family, which exert its
biological functions in humans through YRs (Y1, Y2, Y4 and Y5). Systematic modulation of …

Structural basis for Y2 receptor-mediated neuropeptide Y and peptide YY signaling

H Kang, C Park, YK Choi, J Bae, S Kwon, J Kim, C Choi… - Structure, 2023 - cell.com
Neuropeptide Y (NPY) and its receptors are expressed in various human tissues including
the brain where they regulate appetite and emotion. Upon NPY stimulation, the …